These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1674 related items for PubMed ID: 27566508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J, Ren X, Sun J, Wang X, Qiao HH, Xu BW, Liu LP, Ni JQ.
    J Genet Genomics; 2015 Apr 20; 42(4):141-9. PubMed ID: 25953352
    [Abstract] [Full Text] [Related]

  • 5. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML, Leenay RT, Beisel CL.
    Biotechnol Bioeng; 2016 May 20; 113(5):930-43. PubMed ID: 26460902
    [Abstract] [Full Text] [Related]

  • 6. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R, Wei P, Yang J.
    Methods Mol Biol; 2017 May 20; 1498():33-40. PubMed ID: 27709567
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S, Yamamoto T, Sakuma T.
    Bioengineered; 2017 May 04; 8(3):265-273. PubMed ID: 28140746
    [Abstract] [Full Text] [Related]

  • 12. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T, Georgieva T.
    Circ Res; 2017 Mar 03; 120(5):876-894. PubMed ID: 28254804
    [Abstract] [Full Text] [Related]

  • 13. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR, Pyne ME, Moo-Young M, Chung DA, Chou CP.
    Appl Environ Microbiol; 2016 Oct 15; 82(20):6109-6119. PubMed ID: 27496775
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
    Song M.
    Biotechnol Prog; 2017 Jul 15; 33(4):1035-1045. PubMed ID: 28440027
    [Abstract] [Full Text] [Related]

  • 16. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C, Quan R, Wang J.
    Hum Mol Genet; 2018 Aug 01; 27(R2):R79-R88. PubMed ID: 29659822
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CRISPR-Cas9 technology: applications in genome engineering, development of sequence-specific antimicrobials, and future prospects.
    de la Fuente-Núñez C, Lu TK.
    Integr Biol (Camb); 2017 Feb 20; 9(2):109-122. PubMed ID: 28045163
    [Abstract] [Full Text] [Related]

  • 19. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A.
    Curr Gene Ther; 2018 Feb 20; 18(2):115-124. PubMed ID: 29473500
    [Abstract] [Full Text] [Related]

  • 20. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL.
    Mol Cell; 2017 Oct 05; 68(1):8-14. PubMed ID: 28985512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.